Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

C8 Lawsuits Continue As DuPont Told Plaintifs Do Not Have To Prove Exposure To Sufficient Dose Of C8 Resulted In Diseases Reports Wright & Schulte LLC
  • USA - English


News provided by

Wright & Schulte LLC

Jan 10, 2015, 03:00 ET

Share this article

Share toX

Share this article

Share toX

Judge In C8 Lawsuits Rules Plaintiffs Do Not Have To Prove Sufficient Dose Of C8
Judge In C8 Lawsuits Rules Plaintiffs Do Not Have To Prove Sufficient Dose Of C8

If you believe you or a loved one have been exposed to C8 contaminated drinking water, contact Wright & Schulte LLC for a FREE C8 lawsuit case evaluation at www.yourlegalhelp.com or 1-800-399-0795.

Post this

Columbus, OH (PRWEB) January 10, 2015 -- Wright & Schulte LLC notes a recent a recent ruling by District Judge Edmund Sargus Jr. where he has held to a past 2005 C8 lawsuit settlement agreement that prevents DuPont from challenging the dosage levels of C8 that a panel of medical experts found was the general cause of certain diseases in the community. Judge Sargus, who is presiding over the C8 lawsuits, ruled on December 17 that individual plaintiffs who filed C8 lawsuits in the multidistrict litigation (MDL 2433) against DuPont do not need to show what their individual dose of C8 was nor provide DuPont with “reliable scientific evidence,” such as medical test results, to prove that a “particular dosage was sufficient” to cause their illness. Judge Sargus’ ruling stemmed from the plaintiffs’ motion which asks the judge to clarify that 10 issues, which included the matter of the C8 dosage level, had previously been resolved under the class-action settlement and DuPont cannot challenge these issues in the current C8 lawsuit proceedings. Judge Sargus, who is presiding over the C8 MDL in the U.S. District Court, Southern District of Ohio, granted the plaintiffs’ request. (In Re: E.I. DuPont De Nemours and Company C-8 Personal Injury Litigation, MDL No. 2433) (2005 settlement agreement - Leach v. E.I. Du Pont De Nemours & Co., No. 01-C-608 (W. Va. Cir. Ct.))

The firm is currently representing numerous residents from Ohio and West Virginia in C8 water contamination lawsuits who beleive they have developed such illnesses as thyroid disease, kidney cancer, testicular cancer and other serious diseases caused by exposure to C8 tainted water from DuPont’s Washington Works Plant in Parkersburg West Virginia. Attorney Richard W. Schulte, one of the founding partners and well respected attorney amount his peers, is currently serving on the Plaintiffs’ Steering Committee in C8 litigation. Mr. Schulte was appointed by Judge Sargus who is presiding over C8 lawsuits in the District Court of Southern Ohio.

Wright & Schulte LLC notes there are currently nearly 4,000 C8 water contamination lawsuits pending in C8 Litigation with over 1,400 C8 Lawsuits in U.S. District Court in the Southern District of Ohio (Case No. 2:14-Cv-1673) and more than 2400 C8 lawsuits in the Wood County Circuit Court of West West Virginia (The MDL title is: In Re: E.I. DuPont De Nemours and Company C-8 Personal Injury Litigation, MDL No. 2433).

DuPont was sued in 2001 on behalf of nearly 70,000 Ohio and West Virginia residents who lived or worked near DuPont’s Washington Works Plant near Parkersburg, West Virginia where the toxic C8 chemical was released into the private and drinking water supply. A settlement agreement was reached four years later. (Leach v. E.I. Du Pont De Nemours & Co., No. 01-C-608 (W. Va. Cir. Ct.)) Among the terms of the settlement was the establishment of a C8 Science Panel that would determine whether there were probable links between diseases in the community and exposure to the C8 chemical which DuPont had used for decades at its Washington Works Plant. According to the science panel, perfluorooctanoic acid, or C8 for short, is a man-made chemical used in manufacturing non-stick cookware, and protective finishes on carpets and water-resistant clothing. The panel, consisting of three epidemiologists, found that there was a probable link between C8 and six health disorders:

• High Cholesterol
• Kidney Cancer
• Pregnancy-Induced Hypertension (pre-eclampsia)
• Testicular Cancer
• Thyroid Disease
• Ulcerative Colitis (inflammatory bowel disease)
[c8sciencepanel.org/c8health.html]
[c8sciencepanel.org/prob_link.html]

The class-action settlement agreement also allowed individuals, or their survivors, who lived or worked in one of the six affected water districts in Ohio and West Virginia prior to December 4, 2004, to file a C8 personal injury or wrongful death lawsuit if they, or their loved ones, suffered from a disease which the C8 Science Panel linked to exposure to the C8 chemical. (Leach v. E.I. Du Pont De Nemours & Co., No. 01-C-608 (W. Va. Cir. Ct.)) The six water districts affected by C8 contaminated water are:

• City of Belpre, Ohio
• Little Hocking, Ohio
• Lubeck Public Service District, West Virginia
• Mason County Public Service District, West Virginia
• Tuppers Plains, Ohio
• Village of Pomeroy, Ohio
[c8sciencepanel.org/panel.html]

In its response to the plaintiffs’ motion for partial summary disposition, DuPont argued that the C8 Science Panel’s findings were “limited” and the company reserved its ability to contest all issues, except the issue “that it is probable that exposure to C-8 is capable of causing a particular” probable link condition. In his ruling, Judge Sargus pointed out to DuPont that the company agreed in the original settlement that in any personal injury or wrongful death lawsuit brought by a class-action member, the company would not “contest the issue of general causation between C8 and any human diseases as to which a probable link has been delivered.” (In Re: E.I. DuPont De Nemours and Company C-8 Personal Injury Litigation, MDL No. 2433)

About Wright & Schulte LLC
Wright & Schulte LLC, an experienced personal injury firm, is dedicated to the belief that America’s legal system should work for the people. Every day, the attorneys of Wright Schulte LLC stand up for the rights of people who have been injured or wronged, and fight tirelessly to ensure that even the world’s most powerful corporations take responsibility for their actions. If you’re looking for a law firm that will guarantee the aggressive and personal representation you deserve, please do not hesitate to contact Wright & Schulte LLC today. Free DuPont C8 lawsuit case evaluations are available through yourlegalhelp.com, or call 1-888-399-0795.

Contact:
Wright & Schulte LLC
812 East National Road
Vandalia, Ohio 45377
1-800-399-0795
http://www.yourlegalhelp.com
Like us on Facebook
Follow us on Twitter
Join us on Google+

Richard Schulte, Wright & Schulte LLC, http://yourlegalhelp.com/, +1 1-800-399-0795, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.